Acorai: Difference between revisions
Added valuation: ~€20-40M (€4.2M+ raised) |
Added revenue from allabolag.se (org 559564-5069) |
||
| Line 10: | Line 10: | ||
== What They Do == | == What They Do == | ||
Non-invasive intracardiac pressure monitor for heart failure management. The device measures pressure inside the heart without invasive catheterization, enabling continuous monitoring of heart failure patients.<ref>TechCrunch (2023): "Heart failure monitoring startup Acorai turns heads with oversubscribed seed"</ref> | Non-invasive intracardiac pressure monitor for heart failure management. The device measures pressure inside the heart without invasive catheterization, enabling continuous monitoring of heart failure patients.<ref>TechCrunch (2023): "Heart failure monitoring startup Acorai turns heads with oversubscribed seed"</ref> | ||
== Revenue == | |||
'''Org nr:''' 559564-5069 | |||
'''Source:''' [N/A (no accounts filed) allabolag.se] | |||
* '''2024:''' Pre-revenue | |||
* '''Employees:''' 0 | |||
Non-invasive intracardiac pressure monitor. Pre-revenue. Limhamn. | |||
== Funding == | == Funding == | ||
Latest revision as of 08:09, 14 April 2026
What They Do[edit]
Non-invasive intracardiac pressure monitor for heart failure management. The device measures pressure inside the heart without invasive catheterization, enabling continuous monitoring of heart failure patients.[1]
Revenue[edit]
Org nr: 559564-5069 Source: [N/A (no accounts filed) allabolag.se]
- 2024: Pre-revenue
- Employees: 0
Non-invasive intracardiac pressure monitor. Pre-revenue. Limhamn.
Funding[edit]
Valuation: ~€20-40M (€4.2M+ raised)
Regulatory[edit]
Received FDA Breakthrough Device Designation for their non-invasive intracardiac pressure monitor.[4] This designation accelerates the FDA review process for devices addressing unmet medical needs.
See Also[edit]
- ↑ TechCrunch (2023): "Heart failure monitoring startup Acorai turns heads with oversubscribed seed"
- ↑ MassDevice (2023): "Intracardiac pressure monitoring device startup Acorai raises €2.3M"
- ↑ Silicon Canals (Dec 2024): "Sweden's Acorai bags €4.2M to advance its heart failure management devices"
- ↑ PR Newswire (2024): "Acorai receives Breakthrough Device Designation for their non-invasive intracardiac pressure monitor"